DIN 02487039 — ENGERIX-B 20 MCG
ENGERIX-B is a suspension of Hepatitis B Surface Antigen marketed by GLAXOSMITHKLINE INC. The full Hepatitis B Surface Antigen monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02487039
- Brand name
- ENGERIX-B
- Active ingredient
- Hepatitis B Surface Antigen
- Strength
- 20 MCG
- Dosage form
- SUSPENSION
- Route
- INTRAMUSCULAR
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- Recombinant viral subunit vaccine
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Hepatitis B Surface Antigen products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02487020 | ENGERIX-B | 10 MCG | SUSPENSION | GLAXOSMITHKLINE INC | MARKETED |
| 02561484 | RECOMBIVAX HB | 10 MCG | SOLUTION | MERCK CANADA INC | MARKETED |
| 02245977 | RECOMBIVAX HB | 40 MCG | SUSPENSION | MERCK CANADA INC | MARKETED |
| 02561476 | RECOMBIVAX HB | 5 MCG | SOLUTION | MERCK CANADA INC | MARKETED |